Acuta Capital Partners’s Surrozen SRZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.04M Sell
172,847
-5,568
-3% -$133K 3.55% 8
2025
Q4
$4.03M Hold
178,415
2.74% 11
2025
Q3
$2.3M Buy
178,415
+8,415
+5% +$88.2K 2.38% 13
2025
Q2
$1.52M Hold
170,000
2.12% 16
2025
Q1
$1.98M Buy
+170,000
New +$1.98M 2.3% 18

Other funds holding SRZN

Acuta Capital Partners's SRZN Position: Q1 2026 in Review

Acuta Capital Partners reduced its Surrozen (SRZN) stake by 3.1% in Q1 2026, selling an estimated $133K and leaving 172,847 shares worth $5.04M. The position accounts for 3.55% of the portfolio, ranked #8.

Acuta Capital Partners first reported a position in SRZN in Q1 2025 and has held it in 5 quarters since. 59 funds tracked by Wall St. Rank hold SRZN as of Q1 2026.

  • Acuta Capital Partners held 172,847 shares of Surrozen worth $5.04M as of Q1 2026.
  • Acuta Capital Partners sold 5,568 Surrozen shares in Q1 2026, an estimated $133K.
  • Surrozen made up 3.55% of Acuta Capital Partners's portfolio in Q1 2026, its #8 holding.
  • Acuta Capital Partners first reported a position in Surrozen in Q1 2025 and has held it in 5 quarters since.
  • 59 funds tracked by Wall St. Rank held Surrozen as of Q1 2026.

Based on Acuta Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.